The Raynaud’s Association is pleased to welcome Dr. Richard Silver, director of the Division of Rheumatology and Immunology at the Medical University of South Carolina (MUSC) in Charleston to its Medical Advisory Board.
Dr. Silver is a world-renowned expert in scleroderma and related medical conditions such as Raynaud’s phenomenon. He received his medical degree from the Vanderbilt University School of Medicine and has been in practice for over 25 years.
Under his direction, the MUSC Division of Rheumatology has been consistently ranked among the top 20 programs by U.S. News and World Report.
Raynaud’s Association Founder and Chair Lynn Wunderman noted that most everyone with systemic sclerosis (scleroderma) has Raynaud’s. “Raynaud’s is common in other connective tissue diseases such as lupus and rheumatoid arthritis, and it’s often the first symptom of such life-threatening diseases,” she said. “That’s why it’s so important for such patients to seek medical treatment, to rule out these serious causes.” However, she added, “The good news is that only 10% of Raynaud’s sufferers have the more severe secondary form of the disorder.”
Wunderman said, “We are very privileged to have Dr. Silver’s expertise in offering our members the most up-to-date information in the field of Raynaud’s research and treatment. Our Medical Advisory Board helps us to ensure that the information we provide to our members is accurate and up-to-date.”
Dr. Silver joins a distinguished roster of top Raynaud’s researchers and rheumatologists on the Board. They include Daniel E. Furst, M.D., Carl M. Pearson Professor of Medicine at the University of California, Los Angeles Medical Center; Thomas J.A. Lehman, M.D., former Chief of the Division of Pediatric Rheumatology, Cornell University, Hospital for Special Surgery, NY; and Maureen D. Mayes, M.D., Director, Scleroderma Clinic and Research Program, University of Texas-Houston Medical School.